DB17553InvestigationalSmall molecule
FT-1101 is a novel Bromodomain and Extra-Terminal motif (BET) inhibitor. FT-1101 is under investigation in clinical trial NCT02543879 (Study of a Novel BET Inhibitor FT-1101 in Patients With Relapsed or...
- Code names
- CC-95775 · FT-1101
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of FT-1101, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account